6
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Ex Vivo Conjunctival Retention and Transconjunctival Transport of Poorly Soluble Drugs Using Polymeric Micelles

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This paper addresses the problem of ocular delivery of lipophilic drugs. The aim of the paper is the evaluation of polymeric micelles, prepared using TPGS ( d-α-Tocopheryl polyethylene glycol 1000 succinate), a water-soluble derivative of Vitamin E and/or poloxamer 407, as a vehicle for the ocular delivery of dexamethasone, cyclosporine, and econazole nitrate. The research steps were: (1) characterize polymeric micelles by dynamic light scattering (DLS) and X-ray scattering; (2) evaluate the solubility increase of the three drugs; (3) measure the in vitro transport and conjunctiva retention, in comparison to conventional vehicles; (4) investigate the mechanisms of enhancement, by studying drug release from the micelles and transconjunctival permeation of TPGS; and (5) study the effect of micelles application on the histology of conjunctiva. The data obtained demonstrate the application potential of polymeric micelles in ocular delivery, due to their ability to increase the solubility of lipophilic drugs and enhance transport in and across the conjunctival epithelium. The best-performing formulation was the one made of TPGS alone (micelles size ≈ 12 nm), probably because of the higher mobility of these micelles, an enhanced interaction with the conjunctival epithelium, and, possibly, the penetration of intact micelles.

          Related collections

          Most cited references64

          • Record: found
          • Abstract: not found
          • Article: not found

          Phase Diagrams and Aggregation Behavior of Poly(oxyethylene)-Poly(oxypropylene)-Poly(oxyethylene) Triblock Copolymers in Aqueous Solutions

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Penetration Enhancers in Ocular Drug Delivery

            There are more than 100 recognized disorders of the eye. This makes the development of advanced ocular formulations an important topic in pharmaceutical science. One of the ways to improve drug delivery to the eye is the use of penetration enhancers. These are defined as compounds capable of enhancing drug permeability across ocular membranes. This review paper provides an overview of anatomical and physiological features of the eye and discusses some common ophthalmological conditions and permeability of ocular membranes. The review also presents the analysis of literature on the use of penetration-enhancing compounds (cyclodextrins, chelating agents, crown ethers, bile acids and bile salts, cell-penetrating peptides, and other amphiphilic compounds) in ocular drug delivery, describing their properties and modes of action.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Ophthalmic Drug Dosage Forms: Characterisation and Research Methods

              This paper describes hitherto developed drug forms for topical ocular administration, that is, eye drops, ointments, in situ gels, inserts, multicompartment drug delivery systems, and ophthalmic drug forms with bioadhesive properties. Heretofore, many studies have demonstrated that new and more complex ophthalmic drug forms exhibit advantage over traditional ones and are able to increase the bioavailability of the active substance by, among others, reducing the susceptibility of drug forms to defense mechanisms of the human eye, extending contact time of drug with the cornea, increasing the penetration through the complex anatomical structure of the eye, and providing controlled release of drugs into the eye tissues, which allows reducing the drug application frequency. The rest of the paper describes recommended in vitro and in vivo studies to be performed for various ophthalmic drugs forms in order to assess whether the form is acceptable from the perspective of desired properties and patient's compliance.
                Bookmark

                Author and article information

                Journal
                Pharmaceutics
                Pharmaceutics
                pharmaceutics
                Pharmaceutics
                MDPI
                1999-4923
                14 September 2019
                September 2019
                : 11
                : 9
                : 476
                Affiliations
                [1 ]Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy; silvia.pescina@ 123456unipr.it (S.P.); cristina.padula@ 123456unipr.it (C.P.);
                [2 ]Department of Medicine and Surgery, University of Parma, via Volturno 39, 43126 Parma, Italy; paolo.govoni@ 123456unipr.it
                [3 ]Department of Medical Biotechnologies and Translational Medicine, LITA, University of Milan, 20090 Segrate (MI), Italy; elena.delfavero@ 123456unimi.it (E.D.F.); laura.cantu@ 123456unimi.it (L.C.)
                Author notes
                [* ]Correspondence: sara.nicoli@ 123456unipr.it ; Tel.: +39-0521-905065
                Author information
                https://orcid.org/0000-0002-7596-6251
                https://orcid.org/0000-0002-6584-1869
                https://orcid.org/0000-0001-7601-7894
                https://orcid.org/0000-0001-6955-0957
                Article
                pharmaceutics-11-00476
                10.3390/pharmaceutics11090476
                6781556
                31540066
                60a36f07-9966-46f7-bb81-0f822f770daa
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 15 July 2019
                : 10 September 2019
                Categories
                Article

                ocular delivery,polymeric micelles,conjunctiva,small angle x-ray scattering (saxs),econazole,cyclosporine,dexamethasone,solubility,tpgs,poloxamer 407

                Comments

                Comment on this article